This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $86,335.20, is for the provision of pharmaceutical products and medical supplies to support military healthcare programs.
The contract is a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for AmerisourceBergen to supply a comprehensive range of medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, across multiple therapeutic areas to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
The contract award does not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and there are no major subcontractors mentioned. The funding agency is the DLA, which is responsible for providing medical and pharmaceutical supplies to the U.S. military and other federal healthcare programs.